CBP/p300-IN-15
CBP/p300-IN-15 (compound 13a) is a potent p300/CBP inhibitor, with IC50 values of 2.50 and 28.0 nM, respectively. CBP/p300-IN-15 shows good activity against OVCAR-3 and A2780 cell line, with EC50 values of 0.865 and 2.71 μM, respectively. CBP/p300-IN-15 can be used for ovarian cancer research[1].
Product Specifications
CAS Number
[2379409-91-1]
UNSPSC
12352005
Target
Epigenetic Reader Domain; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbp-p300-in-15.html
Solubility
10 mM in DMSO
Smiles
CNC(NC1=CC=C2C(CC[C@@]23OC(N(C3=O)CC(N4CC5=CC=CC=C5CC[C@H]4C)=O)=O)=C1)=O
Molecular Formula
C26H28N4O5
Molecular Weight
476.52
References & Citations
[1]Ding H, et al. Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer. Bioorg Med Chem. 2021 Dec 15;52:116512.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15113975 1 Vial
Lentiviral human CCNA2 shRNA (UAS) - Lentiviral human CCNA2 shRNA (UAS, RFP) (25)
Ask
View Details MBS1339947-01 0.02 mg (E-Coli)
Recombinant Drosophila pseudoobscura pseudoobscura Cytoplasmic tRNA 2-thiolation protein 1 (GA20807)
Ask
View Details MBS1339947-02 0.02 mg (Yeast)
Recombinant Drosophila pseudoobscura pseudoobscura Cytoplasmic tRNA 2-thiolation protein 1 (GA20807)
Ask
View Details 
MBS1339947-03 0.1 mg (E-Coli)
Recombinant Drosophila pseudoobscura pseudoobscura Cytoplasmic tRNA 2-thiolation protein 1 (GA20807)
Ask
View Details MBS1339947-04 0.1 mg (Yeast)
Recombinant Drosophila pseudoobscura pseudoobscura Cytoplasmic tRNA 2-thiolation protein 1 (GA20807)
Ask
View Details